Laidlaw Begins Coverage on ABIVAX Société Anonyme (NASDAQ:ABVX)
Laidlaw started coverage on shares of ABIVAX Société Anonyme (NASDAQ:ABVX – Free Report) in a research report sent to investors on Monday, MarketBeat.com reports. The firm issued a buy rating and a $48.00 price target on the stock. A number of other brokerages have also issued reports on ABVX. Morgan Stanley raised their price target […]
More Stories
SECURITY COUNCIL LIVE: Ambassadors to meet over deepening Lebanon crisis, with region ‘on the brink of catastrophe’
The Security Council is due to hold an emergency meeting in New York on Friday from 3pm, following Israeli strikes...
Lebanon: WHO appeals for more support for civilians as crises intensify
The international community must come to the aid of Lebanon in the face of back-to-back crises and spillover from the...
News from the WHO: Governments progress on negotiations for a pandemic agreement to boost global preparedness for future emergencies https://ift.tt/Lp23hDT September 20, 2024 at 07:00AM
Published on September 20, 2024 at 07:00AM View on website
Middle East: Regional crisis risks engulfing Syria, UN envoy warns
The escalating regional tensions are drawing Syria deeper into conflict, the UN Special Envoy for the country warned on Tuesday,...
Steelcase (NYSE:SCS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Steelcase (NYSE:SCS – Get Free Report) announced its earnings results on Wednesday. The business services provider reported $0.39 earnings per...
Lawmakers Mull Revamp of Secret Service Funding, Policy After Trump Assassination Attempts
By Joseph Lord and Arjun Singh WASHINGTON, D.C.—In the aftermath of an apparent second attempted assassination of former President Donald...